India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
New Board of Directors and management team at Suven Pharma also appointed
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Clindamycin Phosphate Gel is used to treat acne
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Subscribe To Our Newsletter & Stay Updated
